09/18/2024
3:38 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/17/2024
4:08 PM | Novartis (Filer)
Novartis Capital CORP (Filer)
| Form 424B5 | |
09/17/2024
1:05 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024
4:12 PM | Novartis (Subject)
| Form FWP | |
09/16/2024
7:44 AM | Novartis (Filer)
Novartis Capital CORP (Filer)
| Form 424B5 | |
09/16/2024
7:12 AM | Novartis (Filer)
Novartis Capital CORP (Filer)
| Form F-3ASR | |
08/15/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D/A | |
|
08/13/2024
3:31 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
08/12/2024
2:30 PM | Kowalski Robert William (Reporting)
Novartis (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
7:12 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
08/02/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
08/01/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/31/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/30/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/29/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/25/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/18/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/18/2024
5:09 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
07/05/2024
5:02 AM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T | |
06/21/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D/A | |
06/20/2024
2:38 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-C | |
06/17/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D/A | |
06/10/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D/A | |
06/04/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
05/31/2024
5:00 AM | Novartis (Filer)
| Form SD
Specialized Disclosure Report | |
05/22/2024
11:42 AM | Gal Aharon (Reporting)
Novartis (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
3:31 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
05/07/2024
3:45 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
05/06/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
05/02/2024
3:31 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/25/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/23/2024
5:06 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/18/2024
3:31 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/18/2024
1:33 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC 13D | |
04/17/2024
3:30 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/16/2024
4:07 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/15/2024
2:44 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T/A | |
04/11/2024
5:01 AM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-T | |
02/15/2024
3:15 PM | Novartis (Filer)
| Form S-8 POS | |
If you missed the last crypto boom, you have to see this (Ad) A massive regulatory move is expected in the very near future…
That could send a specific few cryptos soaring.
And while the crypto market is highly volatile… and we can’t promise against losses or guarantee future returns….
We see this as THE BIGGEST opportunity in the crypto market in many years.
The first crypto revolution started with Bitcoin… and a few savvy traders had a shot at absolutely outrageous 14,510% gains or more You have to see THIS right away. |
02/06/2024
3:52 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-C | |
02/05/2024
4:06 PM | MorphoSys AG (Subject)
MorphoSys AG (Subject)
Novartis (Filed by)
| Form SC TO-C | |
02/02/2024
1:18 PM | BlackRock Inc. (Filed by)
Novartis (Subject)
| Form SC 13G/A | |
01/31/2024
6:43 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
6:43 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
6:44 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
6:44 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/31/2024
6:38 AM | Novartis (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
01/31/2024
6:42 AM | Novartis (Filer)
| Form IRANNOTICE | |
01/08/2024
5:13 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2023
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023
7:19 PM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/28/2023
5:10 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2023
5:05 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2023
5:33 AM | Novartis (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
